Engulfed cell remnants, and not cells undergoing apoptosis, constitute the LE-cell phenomenon

References

• Hargraves MM, Richmond H, Morton R. Presentation of two bone marrow elements; the ‘tart'cell and ‘LE’ cell. Proc Staff Meet Mayo Clin 1948; 23: 25–28
   PubMed Web of Science ®Google Scholar
• Hepburn AL. The LE cell. Rheumatology 2001; 40: 826–827
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11)1271–1277
   PubMed Web of Science ®Google Scholar
• Bohm I. Flow cytometric analysis of the LE cell phenomenon. Autoimmunity 2004; 37(1)37–44
   PubMed Web of Science ®Google Scholar
• Bohm I. LE cell phenomenon: Nuclear IgG deposits inhibit enzymatic cleavage of the nucleus of damaged cells and support its phagocytic clearance by PMN. Biomed Pharmacother 2004; 58(3)196–201
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles A, Alarcon-Segovia D. Novel facts about an old marker: The LE cell. Scand J Clin Lab Invest Suppl 2001; 235: 31–37
   PubMedGoogle Scholar
• Schmidt-Acevedo S, Pérez-Romano B, Ruiz-Argüelles A. LE cells result from phagocytosis of apoptotic bodies induced by antinuclear antibodies. J Autoimmun 2000; 15: 15–20
   PubMed Web of Science ®Google Scholar
• Emlen W, Niebur J, Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus. J Immunol 1994; 152(7)3685–3692
   PubMed Web of Science ®Google Scholar
• Rosen A, Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases: Implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ 1999; 6(1)6–12
   PubMed Web of Science ®Google Scholar
• Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorylated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997; 185(5)843–854
   PubMed Web of Science ®Google Scholar
• Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 1994; 179(4)1317–1330
   PubMed Web of Science ®Google Scholar
• Maldonado JE, Alarcon-Segovia D, Pease GL, Brown AL, Jr. Electron microscopy of the lupus erythematosus cell. Mayo Clin Proc 1963; 38: 219–224
   PubMed Web of Science ®Google Scholar
• Schett G, Steiner G, Smolen JS. Nuclear antigen histone H1 is primarily involved in lupus erythematosus cell formation. Arthritis Rheum 1998; 41(8)1446–1455
   PubMed Web of Science ®Google Scholar
• Schett G, Rubin RL, Steiner G, Hiesberger H, Muller S, Smolen J. The lupus erythematosus cell phenomenon: Comparative analysis of antichromatin antibody specificity in lupus erythematosus cell-positive and -negative sera. Arthritis Rheum 2000; 43(2)420–428
   PubMed Web of Science ®Google Scholar
• Brooks CJ, King WJ, Radford DJ, Adu D, McGrath M, Savage CO. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: Relevance to systemic vasculitis. Clin Exp Immunol 1996; 106(2)273–279
   PubMed Web of Science ®Google Scholar
• Ward C, Chilvers ER, Lawson MF, Pryde JG, Fujihara S, Farrow SN, Haslett C, Rossi AG. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem 1999; 274(7)4309–4318
   PubMed Web of Science ®Google Scholar
• Haslett C, Guthrie LA, Kopaniak MM, Johnston RB, Jr., Henson PM. Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 1985; 119(1)101–110
   PubMed Web of Science ®Google Scholar
• Grisham MB, Engerson TD, McCord JM, Jones HP. A comparative study of neutrophil purification and function. J Immunol Methods 1985; 82(2)315–320
   PubMed Web of Science ®Google Scholar
• Matteucci C, Grelli S, De Smaele E, Fontana C, Mastino A. Identification of nuclei from apoptotic, necrotic, and viable lymphoid cells by using multiparameter flow cytometry. Cytometry 1999; 35(2)145–153
   PubMedGoogle Scholar
• Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376(6535)37–43
   PubMed Web of Science ®Google Scholar
• Stummvoll GH, Aringer M, Smolen JS, Koller M, Kiener HP, Steiner CW, Bohle B, Knobler R, Graninger WB. Derangement of apoptosis-related lymphocyte homeostasis in systemic sclerosis. Rheumatology 2000; 39: 1341–1350
   PubMed Web of Science ®Google Scholar
• Boersma AW, Nooter K, Oostrum RG, Stoter G. Quantification of apoptotic cells with fluorescein isothiocyanate-labeled annexin V in Chinese hamster ovary cell cultures treated with cisplatin. Cytometry 1996; 24: 123–130
   PubMedGoogle Scholar
• Graninger WB, Steiner CW, Graninger MT, Aringer M, Smolen JS. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus. Cell Death Differ 2000; 7(10)966–972
   PubMed Web of Science ®Google Scholar
• Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53(8)1945–1951
   PubMed Web of Science ®Google Scholar
• Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G. Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994; 10(2)41–42
   PubMed Web of Science ®Google Scholar
• Graninger WB, Steiner CW, Graninger MT, Aringer M, Smolen JS. Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus. Cell Death Differ 2000; 7(10)966–972
   PubMed Web of Science ®Google Scholar
• Aringer M, Graninger WB, Smolen JS, Kiener HP, Steiner CW, Trautinger F, Knobler R. Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis. Br J Rheumatol 1997; 36(12)1276–1282
   PubMedGoogle Scholar
• Gabler C, Kalden JR, Lorenz HM. The putative role of apoptosis-modified histones for the induction of autoimmunity in systemic lupus erythematosus. Biochem Pharmacol 2003; 66(8)1441–1446
   PubMed Web of Science ®Google Scholar
• Rifkind RA, Godman GC. Phase contrast and interferometric microscopy of the LE cell phenomenon. J Exp Med 1957; 106(4)607–616
   PubMed Web of Science ®Google Scholar
• Lachtermacher M, Houli J. Electron microscopy of L.E. phenomena. Description of the structure of the L.E. cell and L.E. mass. Ann Rheum Dis 1965; 24(6)558–562
   PubMed Web of Science ®Google Scholar
• Perniok A, Wedekind F, Herrmann M, Specker C, Schneider M. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus. Lupus 1998; 7(2)113–118
   PubMed Web of Science ®Google Scholar
• Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis 1999; 58(5)309–314
   PubMed Web of Science ®Google Scholar
• Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum 2003; 48(10)2888–2897
   PubMed Web of Science ®Google Scholar
• Haserick JR. Blood factor in acute disseminated lupus erythematosus; the ‘L.E.’ test. N Y State J Med 1950; 50(20)2445–2446
   PubMedGoogle Scholar
• Aisenberg AC. Studies on the mechanism of the lupus erythematosus (L.E.) phenomenon. J Clin Invest 1959; 38(2)325–333
   PubMed Web of Science ®Google Scholar
• van Nieuwenhuijze AE, van Lopik T, Smeenk RJ, Aarden LA. Time between onset of apoptosis and release of nucleosomes from apoptotic cells: Putative implications for systemic lupus erythematosus. Ann Rheum Dis 2003; 62(1)10–14
   PubMed Web of Science ®Google Scholar
• Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 1998; 41(7)1241–1250
   PubMed Web of Science ®Google Scholar